rethinkPeptides Search
Menu
Study breakdown

GIP Hormone Reduces Inflammation-Induced Nausea Through CGRP Brain Circuits

Animal StudyLow Moderate evidence
The takeaway

GIP receptor activation suppressed both inflammation-driven food aversion (via CGRP neurons) and food intake through separate brain circuits.

Distinct circuits

GIP agonism separates anti-aversion (via CGRP neurons) from appetite suppression through different brain pathways

What the researchers found

GIP receptor agonism blocks IL-1β-induced aversion via parabrachial CGRP neurons while preserving anorexia through a separate circuit.

Why it matters

Understanding how GIP separates nausea from appetite suppression could explain why tirzepatide causes less nausea than pure GLP-1 drugs.

The numbers in context

Mouse study; IL-1-beta used to induce inflammation; parabrachial CGRP neurons required for CTA but not anorexia; dorsal vagal complex GIPR required for anorexia but not anti-aversion.

How the study worked

Preclinical mouse study using GIP agonists, IL-1β challenge, in vivo CGRP neuron activity recording, and circuit-specific manipulations.

Who was studied

Mice (various transgenic lines)

What this study cannot tell us

Preprint — not yet peer-reviewed. Mouse study may not fully translate to human experiences of nausea and appetite.

How to read the evidence

Preprint of a preclinical study — compelling mechanistic data but awaiting peer review and human translation.

When this study was published

Preprint posted in 2025, providing cutting-edge mechanistic insight into dual-incretin pharmacology.

The bigger picture

This explains a key advantage of GIP/GLP-1 dual agonists — the GIP component may reduce the nausea that limits GLP-1-only drug tolerability.

Questions still open

  • Does this explain why tirzepatide has fewer GI side effects than semaglutide?
  • Could selective GIP agonism be used specifically to treat chemotherapy-induced nausea?

Common questions

Why does tirzepatide cause less nausea than semaglutide?
This study suggests the GIP component of tirzepatide specifically blocks nausea-related brain circuits (CGRP neurons) while preserving appetite suppression.
What are parabrachial CGRP neurons?
Brain cells that produce CGRP and control feelings of sickness, food aversion, and nausea — they are a key target for reducing treatment-related nausea.

Read the original research

GIP receptor agonism suppresses inflammation-induced aversion and food intake via distinct circuits.

bioRxiv : the preprint server for biology

Citation

Province, Haley S; Hayes, Nikolas W; Leong, Nathan A; Lorch, Carolyn M; Pekerman, Alexandra; Xia, Jessica L; Beutler, Lisa R. (2025). GIP receptor agonism suppresses inflammation-induced aversion and food intake via distinct circuits.. bioRxiv : the preprint server for biology. https://doi.org/10.1101/2025.08.12.669936